When cross-analyzing ADAMTS8 based on the levels of GATA1 in survival time, lung cancer patients with low-level ADAMTS8 survived for a shorter period when compared with high-level based on low GATA1 but not LMO2 expression. This evidence concerns the gene GATA1 and lung cancer.